lnp023
Showing 1 - 6 of 6
Paroxysmal Nocturnal Hemoglobinuria Trial in Worldwide (LNP023)
Completed
- Paroxysmal Nocturnal Hemoglobinuria
- LNP023
-
Seoul, Korea, Republic of
- +4 more
Apr 5, 2022
Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Worldwide (LNP023, Eculizumab, Ravulizumab)
Active, not recruiting
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
- LNP023
- +2 more
-
Duarte, California
- +39 more
Jan 13, 2023
Primary IgA Nephropathy Trial in Worldwide (LNP023)
Recruiting
- Primary IgA Nephropathy
- LNP023
-
Parkville, Victoria, Australia
- +28 more
Jun 30, 2022
IgA Nephropathy Trial in Worldwide (LNP023, Placebo)
Completed
- IgA Nephropathy
- LNP023
- Placebo
-
Caba, Buenos Aires, Argentina
- +55 more
Jul 7, 2021
IgA Nephropathy Trial in Worldwide (Placebo, LNP023)
Recruiting
- IgA Nephropathy
- Placebo
- LNP023
-
Huntsville, Alabama
- +193 more
Aug 10, 2022